All In Biotech

Drug Trial Radar · NCT00672724

Efficacy of Ramelteon in Adults With Chronic Insomnia

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Subjective Response to Treatment With Ramelteon in Adult Subjects With Chronic Insomnia by Utilizing an Interactive Voice Response System (IVRS) for Collecting Diary Data

Last checked: Nov 20, 2026Latest source record: Feb 28, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 1,081 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,081

Actual

Start

Feb 2005

Primary completion

Aug 2005

Study completion Aug 2005

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
May 6, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate subjectively reported treatment effects of ramelteon, once daily (QD), in adults with chronic insomnia.

Conditions

  • Chronic Insomnia

Interventions

  • RamelteonDrug

    Ramelteon 8 mg tablets, taken orally, once daily for up to 2 weeks.

  • PlaceboDrug

    Ramelteon placebo-matching tablets, taken orally, once daily for up to 2 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Subjective Sleep Latency determined through subject responses on morning questionnaire.Time frame: Day 8

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Mesa, Arizona

  • Site not named

    Phoenix, Arizona

  • Site not named

    Scottsdale, Arizona

  • Site not named

    Hot Springs, Arkansas

  • Site not named

    Cerritos, California

  • Site not named

    La Jolla, California

  • Site not named

    La Mesa, California

  • Site not named

    Oakland, California

  • Site not named

    Denver, Colorado

  • Site not named

    Bay Harbor Island, Florida

  • Site not named

    Brandon, Florida

  • Site not named

    Clearwater, Florida

  • Site not named

    DeLand, Florida

  • Site not named

    Fort Lauderdale, Florida

  • Site not named

    Fort Myers, Florida

  • Site not named

    Hollywood, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Pembroke Pines, Florida

  • Site not named

    Pinellas Park, Florida

  • Site not named

    Vero Beach, Florida

  • Site not named

    Atlanta, Georgia

  • Site not named

    Austell, Georgia

  • Site not named

    Macon, Georgia

  • Site not named

    Boise, Idaho

  • Site not named

    Northbrook, Illinois

  • Site not named

    Prairie Village, Kansas

  • Site not named

    Wichita, Kansas

  • Site not named

    Louisville, Kentucky

  • Site not named

    Frederick, Maryland

  • Site not named

    Moorestown, New Jersey

  • Site not named

    Menlius, New York

  • Site not named

    New York, New York

  • Site not named

    Williamsville, New York

  • Site not named

    Salem, North Carolina

  • Site not named

    Winston-Salem, North Carolina

  • Site not named

    Cincinnati, Ohio

  • Site not named

    Mogadore, Ohio

  • Site not named

    Philadelphia, Pennsylvania

  • Site not named

    Bristol, Tennessee

  • Site not named

    Chattanooga, Tennessee

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.